Single nucleotide polymorphisms (SNPs) are often associated with conferring risk for disease, and are associated with many complex diseases such as breast and ovarian cancer. The BRCA1 gene is known to carry mutations that can predispose an individual to such diseases. Currently, the clinical significance of most SNPs remains unknown due to the lack of successful and reliable classification tools, leading to the possibility that many pathogenic SNPs are not considered during genetic screening. In order to investigate the role of SNPs within crucial pathways and the structural effects of SNPs, a database and data collection pipeline was constructed that sourced information from Reactome, ClinVar, and UniProt. A second pipeline was created th...
Background: Genome-wide association studies of common diseases for common, low penetrance causal var...
Single nucleotide variants are the most frequent type of sequence changes detected in the genome and...
International audienceBRCA1 mutations have been identified that increase the risk of developing here...
AbstractSingle-nucleotide polymorphisms (SNPs) play a major role in the understanding of the genetic...
Germline pathogenic variants in the breast cancer type 1 susceptibility gene BRCA1 are associated wi...
Germline mutations in the tumor suppressor gene BRCA1 confer an estimated lifetime risk of 56-80% fo...
Background Inactivating germline mutations in the tumour suppressor gene BRCA1 are associated with a...
Background Inactivating germline mutations in the tumour suppressor gene BRCA1 are associated with a...
With the completion of the human genome project at the beginning of the 21st century, the biological...
Single nucleotide variants are the most frequent type of sequence changes detected in the genome and...
Selecting a subset of SNPs (Single Nucleotide Polymorphism pronounced snip) that is informative and ...
Single nucleotide variants are the most frequent type of sequence changes detected in the genome and...
Recent developments in clinical patient-based personalized genomics explored a variety of biomarkers...
With the completion of the human genome project at the beginning of the 21st century, the biological...
456-462The role of single nucleotide polymorphs (SNPs) in genes that modulate or promote cancer proc...
Background: Genome-wide association studies of common diseases for common, low penetrance causal var...
Single nucleotide variants are the most frequent type of sequence changes detected in the genome and...
International audienceBRCA1 mutations have been identified that increase the risk of developing here...
AbstractSingle-nucleotide polymorphisms (SNPs) play a major role in the understanding of the genetic...
Germline pathogenic variants in the breast cancer type 1 susceptibility gene BRCA1 are associated wi...
Germline mutations in the tumor suppressor gene BRCA1 confer an estimated lifetime risk of 56-80% fo...
Background Inactivating germline mutations in the tumour suppressor gene BRCA1 are associated with a...
Background Inactivating germline mutations in the tumour suppressor gene BRCA1 are associated with a...
With the completion of the human genome project at the beginning of the 21st century, the biological...
Single nucleotide variants are the most frequent type of sequence changes detected in the genome and...
Selecting a subset of SNPs (Single Nucleotide Polymorphism pronounced snip) that is informative and ...
Single nucleotide variants are the most frequent type of sequence changes detected in the genome and...
Recent developments in clinical patient-based personalized genomics explored a variety of biomarkers...
With the completion of the human genome project at the beginning of the 21st century, the biological...
456-462The role of single nucleotide polymorphs (SNPs) in genes that modulate or promote cancer proc...
Background: Genome-wide association studies of common diseases for common, low penetrance causal var...
Single nucleotide variants are the most frequent type of sequence changes detected in the genome and...
International audienceBRCA1 mutations have been identified that increase the risk of developing here...